Endologix Inc (ELGX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Endologix Inc (ELGX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7516
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Endologix, Inc. (Endologix) is a medical device company. It undertakes the development, manufacturing and selling of minimally invasive treatments for aortic diseases. The company lays focus on its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). The company’s AAA products are built on traditional minimally-invasive endovascular repair (EVAR) platform or endovascular sealing (EVAS) platform. The company’s EVAR products include AFX endovascular AAA system Vela Proximal Endograft and Intuitrak endovascular AAA system; and EVAS products comprise Nellix endovascular aneurysm sealing system. It has manufacturing facility in Irvine. The company sells its products to hospitals in the US and Europe through direct sales force and through third-party international distributors and agents in other parts of the world. Endologix is headquartered in California, the US.

Endologix Inc (ELGX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Endologix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endologix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Endologix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endologix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Endologix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Endologix Inc, Medical Equipment, Deal Details 12
Venture Financing 12
TriVascular Raises US$2 Million In Venture Financing 12
TriVascular Raises US$40 Million In Series E Financing 13
TV2 Raises US$0.07 Million In Venture Financing 15
Trivascular Raises Funds Through Initial Tranche Of Series D Financing 16
TriVascular Raises US$7.2 Million In Venture Financing 18
Partnerships 19
Endologix Enters into Co-Development Agreement with Japan Lifeline 19
Equity Offering 20
Endologix Plans to Raise Funds through Public Offering of Shares 20
Endologix Raises USD210 Million in Private Placement 21
Endologix Plans to Raise USD100 Million in Public Offering of Securities 22
Endologix Plans to Raise USD46.2 Million in Equity Offering of Shares 23
TriVascular Technologies Completes IPO For US$89.7 Million 24
Endologix Completes Public Offering Of Common Stock For US$40 Million 26
Debt Offering 27
Endologix Raises USD125 Million in Public Offering of 3.25% Notes Due 2020 27
TriVascular Raises USD10 Million in Private Placement 29
Endologix Completes Public Offering Of Notes Due 2018 For US$86.3 Million 30
Acquisition 32
Endologix Acquires TriVascular Technologies 32
Endologix Inc – Key Competitors 34
Endologix Inc – Key Employees 35
Endologix Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Financial Announcements 37
Oct 02, 2018: Endologix Announces Third Quarter Preliminary Revenue Results and Raises Low End of 2018 Revenue Guidance Range 37
Aug 09, 2018: Endologix reports second quarter 2018 financial results 38
May 02, 2018: Endologix Announces First Quarter 2018 Financial Results 39
Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results 40
Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results 42
Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 43
May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 44
Feb 22, 2017: Endologix Reports Results for the Fourth Quarter and Full Year 2016 45
Corporate Communications 47
Aug 15, 2018: Endologix appoints Jeffrey S. Brown as Chief Operations Officer 47
Jun 25, 2018: Endologix Names Jeffry Fecho As Chief Quality Officer 48
May 02, 2018: Endologix Names John Onopchenko As Chief Executive Officer 49
Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer 50
Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer 51
Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer 52
Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer 53
Feb 06, 2017: Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables
Endologix Inc, Medical Equipment, Key Facts, 2017 2
Endologix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Endologix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endologix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Endologix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endologix Inc, Deals By Market, 2012 to YTD 2018 9
Endologix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
TriVascular Raises US$2 Million In Venture Financing 12
TriVascular Raises US$40 Million In Series E Financing 13
TV2 Raises US$0.07 Million In Venture Financing 15
Trivascular Raises Funds Through Initial Tranche Of Series D Financing 16
TriVascular Raises US$7.2 Million In Venture Financing 18
Endologix Enters into Co-Development Agreement with Japan Lifeline 19
Endologix Plans to Raise Funds through Public Offering of Shares 20
Endologix Raises USD210 Million in Private Placement 21
Endologix Plans to Raise USD100 Million in Public Offering of Securities 22
Endologix Plans to Raise USD46.2 Million in Equity Offering of Shares 23
TriVascular Technologies Completes IPO For US$89.7 Million 24
Endologix Completes Public Offering Of Common Stock For US$40 Million 26
Endologix Raises USD125 Million in Public Offering of 3.25% Notes Due 2020 27
TriVascular Raises USD10 Million in Private Placement 29
Endologix Completes Public Offering Of Notes Due 2018 For US$86.3 Million 30
Endologix Acquires TriVascular Technologies 32
Endologix Inc, Key Competitors 34
Endologix Inc, Key Employees 35
Endologix Inc, Subsidiaries 36

List of Figures
Endologix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Endologix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Endologix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Endologix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Endologix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Endologix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Endologix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Endologix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Endologix Inc (ELGX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mobidiag Ltd:企業の製品パイプライン分析
    Summary Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screeni …
  • Team Energy Corp:企業の戦略的SWOT分析
    Team Energy Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • K’s Holdings Corporation:企業の戦略・SWOT・財務情報
    K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary K's Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Lee Enterprises, Inc. (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises, Inc. (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Global Bio-chem Technology Group Company Limited (809):企業の財務・戦略的SWOT分析
    Global Bio-chem Technology Group Company Limited (809) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Nielsen Holdings plc (NLSN):企業の財務・戦略的SWOT分析
    Nielsen Holdings plc (NLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Magnit:企業の戦略・SWOT・財務分析
    Magnit - Strategy, SWOT and Corporate Finance Report Summary Magnit - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Daybreak Oil and Gas Inc (DBRM):石油・ガス:M&Aディール及び事業提携情報
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • News Corporation:企業の戦略・SWOT・財務情報
    News Corporation - Strategy, SWOT and Corporate Finance Report Summary News Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Panoro Energy ASA (PEN):企業の財務・戦略的SWOT分析
    Summary Panoro Energy ASA (Panoro) is an independent oil and gas exploration and development company that explores, develops and produces oil and gas properties in Brazil and West Africa. The company holds interests in production and exploration assets in Santos and Camamu Almada basins in Brazil. I …
  • Cisco Systems, Inc.:企業のM&A・事業提携・投資動向
    Cisco Systems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cisco Systems, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Manappuram Finance Limited (MANAPPURAM):企業の財務・戦略的SWOT分析
    Manappuram Finance Limited (MANAPPURAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Colas SA (RE):企業の財務・戦略的SWOT分析
    Colas SA (RE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Sumitomo Heavy Industries Ltd (6302)
    Sumitomo Heavy Industries Ltd (6302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • King Yuan Electronics Co Ltd (2449):企業の財務・戦略的SWOT分析
    King Yuan Electronics Co Ltd (2449) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Genetic Technologies Ltd (GTG):企業の製品パイプライン分析
    Summary Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneT …
  • CAS Medical Systems Inc (CASM):企業の財務・戦略的SWOT分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Alamos Gold Inc.:企業の戦略・SWOT・財務情報
    Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamos Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務分析
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆